Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PD-1/PD-L1 inhibitors in haematological malignancies: update 2017.
Jelinek T, Mihalyova J, Kascak M, Duras J, Hajek R. Jelinek T, et al. Among authors: mihalyova j. Immunology. 2017 Nov;152(3):357-371. doi: 10.1111/imm.12788. Epub 2017 Aug 4. Immunology. 2017. PMID: 28685821 Free PMC article. Review.
Venetoclax: A new wave in hematooncology.
Mihalyova J, Jelinek T, Growkova K, Hrdinka M, Simicek M, Hajek R. Mihalyova J, et al. Exp Hematol. 2018 May;61:10-25. doi: 10.1016/j.exphem.2018.02.002. Epub 2018 Mar 2. Exp Hematol. 2018. PMID: 29477371 Free article. Review.
Single-agent venetoclax induces MRD-negative response in relapsed primary plasma cell leukemia with t(11;14).
Jelinek T, Mihalyova J, Kascak M, Duras J, Popkova T, Benkova K, Richterova P, Plonkova H, Zuchnicka J, Broskevicova L, Huvarova L, Cerna L, Growkova K, Simicek M, Havel M, Gumulec J, Navratil M, Koristek Z, Paiva B, Hajek R. Jelinek T, et al. Among authors: mihalyova j. Am J Hematol. 2019 Jan;94(1):E35-E37. doi: 10.1002/ajh.25331. Epub 2018 Nov 25. Am J Hematol. 2019. PMID: 30370955 Free article. No abstract available.
Cytarabine + G-CSF is more effective than cyclophosphamide + G-CSF as a stem cell mobilization regimen in multiple myeloma.
Jelinek T, Adamusova L, Popkova T, Tvrda I, Smejkalova J, Simicek M, Salounova D, Kascak M, Mihalyova J, Plonkova H, Duras J, Navratil M, Hajek R, Koristek Z. Jelinek T, et al. Among authors: mihalyova j. Bone Marrow Transplant. 2019 Jul;54(7):1107-1114. doi: 10.1038/s41409-018-0396-x. Epub 2018 Nov 20. Bone Marrow Transplant. 2019. PMID: 30459429
[CD38 targeted treatment for multiple myeloma].
Jelínek T, Mihályová J, Hájek R. Jelínek T, et al. Among authors: mihalyova j. Vnitr Lek. 2018 Fall;64(10):939-948. Vnitr Lek. 2018. PMID: 30590941 Czech.
15 results